LGALS3 and urothelial carcinoma: Canesin et al. reported that increased galectin-3 staining in bladder urothelial carcinomas was associated with progressive disease and reduced survival, while Kramer et al. found that decreased galectin-3 expression was linked to a higher frequency of recurrence in non-invasive urothelial carcinomas [33,34].